Portal de Periódicos da CAPES

An Overview of Intravesical Therapy for Superficial Bladder Tumors

1987; Lippincott Williams & Wilkins; Volume: 138; Issue: 6 Linguagem: Inglês

10.1016/s0022-5347(17)43644-5

1527-3792

Harry W. Herr, Vincent P. Laudone, Willet F. Whitmore,

Urological Disorders and Treatments

No AccessJournal of UrologyReview Article1 Dec 1987An Overview of Intravesical Therapy for Superficial Bladder Tumors Harry W. Herr, Vincent P. Laudone, and Willet F. Whitmore Harry W. HerrHarry W. Herr More articles by this author , Vincent P. LaudoneVincent P. Laudone More articles by this author , and Willet F. WhitmoreWillet F. Whitmore More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)43644-5AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail © 1987 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited ByCookson M, Herr H, Zhang Z, Soloway S, Sogani P and Fair W (2018) The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year OutcomeJournal of Urology, VOL. 158, NO. 1, (62-67), Online publication date: 1-Jul-1997.Ali-El-Dein B, El-Baz M, Aly A, Shamaa S and Ashamallah A (2018) Intravesical Epirubicin Versus Doxorubicin for Superficial Bladder Tumors (Stages pTa and pT1): a Randomized Prospective StudyJournal of Urology, VOL. 158, NO. 1, (68-74), Online publication date: 1-Jul-1997.Asakura T, Takano Y, Iki M, Suwa Y, Noguchi S, Kubota Y and Masuda M (2018) Prognostic Value of Ki-67 for Recurrence and Progression of Superficial Bladder CancerJournal of Urology, VOL. 158, NO. 2, (385-388), Online publication date: 1-Aug-1997.Di Stasi S, Giannantoni A, Massoud R, Cortese C, Vespasiani G and Micali F (2018) Electromotive Administration of Oxybutynin into the Human Bladder WallJournal of Urology, VOL. 158, NO. 1, (228-233), Online publication date: 1-Jul-1997.Nakagawa M, Emoto A, Nasu N, Hanada T, Kuwano M, Cole S and Nomura Y (2018) Clinical Significance of Multi-Drug Resistance Associated Protein and P-Glycoprotein in Patients with Bladder CancerJournal of Urology, VOL. 157, NO. 4, (1260-1265), Online publication date: 1-Apr-1997.Yu D, Chang S and Ma C (2018) The Correlation of Membranous Glycoprotein-GP-170, Cytoplasmic Glutathione and Glucose-6-Phosphate Dehydrogenase Levels with Multidrug Resistance in Transitional Cell Carcinoma Cell Lines of the Urinary TractJournal of Urology, VOL. 157, NO. 2, (727-731), Online publication date: 1-Feb-1997.Pawinski A, Sylvester R, Kurth K, Bouffioux C, Van Der Meijden A, Parmar M and Bijnens L (2018) A Combined Analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council Randomized Clinical Trials for the Prophylactic Treatment of Stage TaT1 Bladder CancerJournal of Urology, VOL. 156, NO. 6, (1934-1941), Online publication date: 1-Dec-1996.Okamoto E, Kinne R and Sokeland J (2018) Interferons Modify in Vitro Proliferation of Human Bladder Transitional Cell Carcinoma in the Presence of Doxorubicin and Mitomycin CJournal of Urology, VOL. 156, NO. 4, (1492-1495), Online publication date: 1-Oct-1996.Narayan P (2018) Editorial: Transitional Cell CarcinomaJournal of Urology, VOL. 156, NO. 2, (389-390), Online publication date: 1-Aug-1996.Colombo R, Da Pozzo L, Lev A, Freschi M, Gallus G and Rigatti P (2018) Neoadjuvant Combined Microwave Induced Local Hyperthermia and Topical Chemotherapy Versus Chemotherapy Alone for Superficial Bladder CancerJournal of Urology, VOL. 155, NO. 4, (1227-1232), Online publication date: 1-Apr-1996.Mizutani Y, Okada Y, Terachi T and Yoshida O (2018) Prognostic Significance of Circulating Cytotoxic Lymphocytes Against Autologous Tumors in Patients With Bladder CancerJournal of Urology, VOL. 155, NO. 3, (888-894), Online publication date: 1-Mar-1996. (2018) EDITORIAL COMMENTJournal of Urology, VOL. 153, NO. 5, (1450-1450), Online publication date: 1-May-1995.Glazier D, Bahnson R, McLeod D, von Roemeling R, Messing E and Ernstoff M (2018) Intravesical Recombinant Tumor Necrosis Factor in the Treatment of Superficial Bladder Cancer: An Eastern Cooperative Oncology Group StudyJournal of Urology, VOL. 154, NO. 1, (66-68), Online publication date: 1-Jul-1995.Bouffioux C, Kurth K, Bono A, Oosterlinck W, Kruger C, De Pauw M and Sylvester R (2018) Original Articles: Bladder Cancer: Intravesical Adjuvant Chemotherapy for Superficial Transitional Cell Bladder Carcinoma: Results of 2 European Organization for Research and Treatment of Cancer Randomized Trials With Mitomycin C and Doxorubicin Comparing Early Versus Delayed Instillations and Short-Term Versus Long-Term TreatmentJournal of Urology, VOL. 153, NO. 3S, (934-941), Online publication date: 1-Mar-1995.Kamat M, Kulkarni J, Tongaonkar H and Dalal A (2018) Intravesical Bacillus Calmette-Guerin For Superficial Bladder Cancer: Experience With Danish 1331 StrainJournal of Urology, VOL. 152, NO. 5 Part 1, (1424-1428), Online publication date: 1-Nov-1994.Chai M, Wientjes M, Badalament R, Burgers J and Au J (2018) Pharmacokinetics of Intravesical Doxorubicin in Superficial Bladder Cancer PatientsJournal of Urology, VOL. 152, NO. 2 Part 1, (374-378), Online publication date: 1-Aug-1994.Soloway M (2018) Editorial: Intravesical Therapy for Bladder CancerJournal of Urology, VOL. 152, NO. 2 Part 1, (379-381), Online publication date: 1-Aug-1994.Kiemeney L, Witjes J, Heijbroek R, Verbeek A and Debruyne F (2018) Predictability of Recurrent and Progressive Disease in Individual Patients with Primary Superficial Bladder CancerJournal of Urology, VOL. 150, NO. 1, (60-64), Online publication date: 1-Jul-1993.Chang B, Liang Y, Miller D, Bergeron R, Porter C and Wang G (2018) Effects of Diethyl Spermine Analogues in Human Bladder Cancer Cell Lines in CultureJournal of Urology, VOL. 150, NO. 4, (1293-1297), Online publication date: 1-Oct-1993.Lipponen P, Eskelinen M, Jauhiainen K, Harju E, Terho R and Haapasalo H (2018) Grading of Superficial Bladder Cancer by Quantitative Mitotic Frequency AnalysisJournal of Urology, VOL. 149, NO. 1, (36-41), Online publication date: 1-Jan-1993.Melekos M, Chionis H, Pantazakos A, Fokaefs E, Paranychianakis G and Dauaher H (2018) Intravesical Bacillus Calmette-Guerin Immunoprophylaxis of Superficial Bladder Cancer: Results of a Controlled Prospective Trial with Modified Treatment ScheduleJournal of Urology, VOL. 149, NO. 4, (744-748), Online publication date: 1-Apr-1993.Heinzer H, Huland E, Mönk M and Huland H (2018) Distribution of 486P 3/12 Antigen, Abo(H) Blood Group Antigen and T Antigen in Cystectomy Specimens from Patients with Stage T2 Transitional Cell Carcinoma of the BladderJournal of Urology, VOL. 148, NO. 3 Part 1, (802-805), Online publication date: 1-Sep-1992.Böhle A, Kirsten D, Schröder K, Knipper A, Fornara P, Magnussen H and Jocham D (2018) Clinical Evidence of Systemic Persistence of Bacillus Calmette-Guerin: Long-Term Pulmonary Bacillus Calmette-Guerin Infection After Intravesical Therapy for Bladder Cancer and Subsequent CystectomyJournal of Urology, VOL. 148, NO. 6, (1894-1897), Online publication date: 1-Dec-1992.Lamm D (2018) Editorial CommentsJournal of Urology, VOL. 148, NO. 3 Part 1, (801-801), Online publication date: 1-Sep-1992.Herr H (2018) Progression of Stage T1 Bladder Tumors After Intravesical Bacillus Calmette-GuerinJournal of Urology, VOL. 145, NO. 1, (40-43), Online publication date: 1-Jan-1991.Steinberg G, Brendler C, Squire R and Isaacs J (2018) Experimental Intravesical Therapy for Superficial Transitional Cell Carcinoma in a Rat Bladder Tumor ModelJournal of Urology, VOL. 145, NO. 3, (647-653), Online publication date: 1-Mar-1991.Böhle A, Gerdes J, Ulmer A, Hofstetter A and Flad H (2018) Effects of Local Bacillus Calmette-Guerin Therapy in Patients with Bladder Carcinoma on Immunocompetent Cells of the Bladder WallJournal of Urology, VOL. 144, NO. 1, (53-58), Online publication date: 1-Jul-1990.Böhle A, Nowc C, Ulmer A, Musehold J, Gerdes J, Hofstetter A and Flad H (2018) Elevations of Cytokines Interleukin-1, Interleukin-2 and Tumor Necrosis Factor in the Urine of Patients after Intravesical Bacillus Calmette-Guerin ImmunotherapyJournal of Urology, VOL. 144, NO. 1, (59-64), Online publication date: 1-Jul-1990.Huland H, Klöppel G, Feddersen I, Otto U, Brachmann W, Hubmann H, Kaufmann J, Knipper W, Lantzius-Beninga F and Huland E (2018) Comparison of Different Schedules of Cytostatic Intravesical Instillations in Patients with Superficial Bladder Carcinoma: Final Evaluation of a Prospective Multicenter Study with 419 PatientsJournal of Urology, VOL. 144, NO. 1, (68-71), Online publication date: 1-Jul-1990.Ratliff T (2018) Editorial CommentsJournal of Urology, VOL. 144, NO. 1, (71-71), Online publication date: 1-Jul-1990.Bitsch M, Hermann G, Andersen J and Steven K (2018) Low Dose Intravesical Heparin as Prophylaxis against Recurrent Noninvasive(Stage Ta) Bladder CancerJournal of Urology, VOL. 144, NO. 3, (635-636), Online publication date: 1-Sep-1990.Huland E, Huland H and Schneider A (2018) Quantitative Immunocytology in the Management of Patients with Superficial bladder Carcinoma. I. A Marker to Identify Patients Who do not Require ProphylaxisJournal of Urology, VOL. 144, NO. 3, (637-639), Online publication date: 1-Sep-1990.Glashan R (2018) A Randomized Controlled Study of Intravesical α−2b-Interferon in Carcinoma in Situ of the BladderJournal of Urology, VOL. 144, NO. 3, (658-661), Online publication date: 1-Sep-1990.Herr H (2018) Outpatient Flexible Cystoscopy and Fulguration of Recurrent Superficial Bladder TumorsJournal of Urology, VOL. 144, NO. 6, (1365-1366), Online publication date: 1-Dec-1990.Martínez Piñeiro J, León J, Martínez Piñeiro L, Fiter L, Mosteiro J, Navarro J, García Matres M and Cárcamo P (2018) Bacillus Calmette-Guerin Versus Doxorubicin Versus Thiotepa: A Randomized Prospective Study in 202 Patients with Superficial Bladder CancerJournal of Urology, VOL. 143, NO. 3, (502-506), Online publication date: 1-Mar-1990.Soloway M (2018) Editorial CommentsJournal of Urology, VOL. 144, NO. 1, (71-72), Online publication date: 1-Jul-1990.Dow J, di Sant’agnese P and Cockett A (2018) Expression of Blood Group Precursor T Antigen as a Prognostic Marker for Human Bladder Cancer Treated by Bacillus Calmette-Guerin And Interleukin-2Journal of Urology, VOL. 142, NO. 4, (978-981), Online publication date: 1-Oct-1989.Ratliff T (2018) Editorial CommentsJournal of Urology, VOL. 142, NO. 4, (981-982), Online publication date: 1-Oct-1989.Mitchell I, Hayward S, Deshpande N and Towler J (2018) Enzyme Studies in Human Transitional Cell Carcinoma of the Urinary BladderJournal of Urology, VOL. 141, NO. 5, (1234-1237), Online publication date: 1-May-1989.Kim H and Lee C (2018) Intravesical Mitomycin C Instillation as a Prophylactic Treatment of Superficial Bladder TumorJournal of Urology, VOL. 141, NO. 6, (1337-1339), Online publication date: 1-Jun-1989.Homma Y, Kakizoe T, Samma S and Oyasu R (2018) Suppression of Rat Urinary Bladder Carcinogenesis by α-DifluoromethylornithineJournal of Urology, VOL. 141, NO. 6, (1454-1457), Online publication date: 1-Jun-1989.Kato K, Kitada S, Chun A, Wein A and Levin R (2018) In Vitro Intravesical Instillation of Anticholinergic, Antispasmodic and Calcium Blocking Agents (Rabbit Whole Bladder Model)Journal of Urology, VOL. 141, NO. 6, (1471-1475), Online publication date: 1-Jun-1989. Volume 138Issue 6December 1987Page: 1363-1368 Advertisement Copyright & Permissions© 1987 by The American Urological Association Education and Research, Inc.MetricsAuthor Information Harry W. Herr More articles by this author Vincent P. Laudone More articles by this author Willet F. Whitmore More articles by this author Expand All Advertisement PDF DownloadLoading ...